
The resignation of top FDA vaccine official Dr. Peter Marks in the wake of vaccine safety controversies and accusations against HHS Secretary Robert F. Kennedy Jr. sheds light on troubling issues within the agency.
Dr. Marks, who oversaw vaccine approvals at the FDA, sent his resignation letter to Acting FDA Commissioner Sara Brenner, stating he would retire by April 5.
Multiple sources reported he was given an ultimatum: resign or be fired.
His departure comes as Kennedy implements sweeping changes at HHS, including plans to cut 20,000 workers from what he calls a bloated bureaucracy.
Marks’s resignation letter pulled no punches, directly accusing Kennedy of prioritizing his anti-vaccine agenda over scientific truth.
“It has become clear that truth and transparency are not desired by the secretary, but rather he wishes subservient confirmation of his misinformation and lies,” Marks wrote in his scathing rebuke.
This high-profile departure comes as patriots have long questioned the cozy relationship between government health agencies and pharmaceutical companies.
Under Kennedy’s direction, independent federal vaccine advisory committees have been postponed, NIH vaccine research terminated, and a new study on vaccines and autism initiated—addressing concerns many conservatives have raised for years.
Kennedy’s supporters view these changes as a necessary reform of agencies that rushed experimental COVID vaccines to market under Operation Warp Speed.
Despite having worked on that Trump administration initiative, Marks now finds himself on the outside looking in as Kennedy fulfills campaign promises to investigate vaccine injuries and restore scientific integrity to federal health agencies.
RFK, who has long questioned the safety of vaccines, promised during his Senate confirmation hearings not to undermine vaccine confidence.
However, his critics in the medical establishment, including former FDA Commissioner Dr. Robert Califf, have expressed alarm at the direction HHS is taking under his leadership.
The timing of Marks’s departure coincides with a measles outbreak spreading across multiple states, which establishment health officials attribute to declining vaccination rates.
This outbreak threatens America’s status of eliminating the disease’s local spread, with nearly 500 cases reported across 19 states.
Although the medical establishment mourns Marks’ departure, many conservative Americans welcome Kennedy’s bold approach to reforming HHS.
The Secretary has blamed the department’s inefficiency and its workers for declining American health outcomes, and his promise to cut bureaucratic bloat resonates with taxpayers tired of government waste.
As Kennedy restructures HHS, focusing on studying long COVID, vaccine injuries, and Lyme disease, he aims to reset the department’s priorities to serve everyday Americans better.
Kennedy’s shakeup represents a long-overdue reckoning for patriots frustrated with decades of government health policies that seemed to benefit Big Pharma more than citizens.